Immix Biopharma is a biotech company developing new cancer and inflammation treatments. Their lead drug (IMX-110) is in clinical trials and uses a special technology to attack tumors and their surrounding environment.
Immix Biopharma is a biotech company developing new cancer and inflammation treatments. Their lead drug (IMX-110) is in clinical trials and uses a special technology to attack tumors and their surrounding environment.